| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.64B | 16.90B | 18.41B | 17.35B | 21.50B | 16.43B |
| Gross Profit | 6.81B | 6.84B | 7.25B | 6.68B | 7.89B | 5.93B |
| EBITDA | 3.39B | 3.36B | 3.64B | 3.00B | 3.57B | 2.68B |
| Net Income | 2.07B | 2.06B | 2.30B | 1.91B | 2.25B | 1.92B |
Balance Sheet | ||||||
| Total Assets | 20.99B | 20.02B | 19.81B | 19.64B | 20.52B | 17.44B |
| Cash, Cash Equivalents and Short-Term Investments | 3.95B | 4.08B | 3.52B | 4.09B | 3.22B | 3.68B |
| Total Debt | 4.12B | 4.39B | 4.33B | 4.40B | 4.61B | 3.64B |
| Total Liabilities | 6.33B | 6.37B | 6.73B | 7.11B | 7.77B | 6.03B |
| Stockholders Equity | 13.65B | 12.71B | 12.08B | 11.56B | 11.71B | 10.74B |
Cash Flow | ||||||
| Free Cash Flow | 1.93B | 2.28B | 985.45M | 2.50B | 363.28M | 655.85M |
| Operating Cash Flow | 3.42B | 3.32B | 2.55B | 4.06B | 2.32B | 1.92B |
| Investing Cash Flow | -863.62M | -1.55B | -1.54B | -1.59B | -995.57M | -2.73B |
| Financing Cash Flow | -2.11B | -1.50B | -1.28B | -1.41B | -956.19M | 1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$267.75M | 6.76 | 6.01% | 7.76% | 14.80% | -56.27% | |
71 Outperform | HK$441.17M | 10.15 | 6.19% | 12.90% | 0.71% | 2.66% | |
69 Neutral | HK$16.52B | 3.65 | 15.70% | 5.53% | -6.39% | -10.18% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
44 Neutral | HK$163.20M | -2.52 | -11.99% | 31.48% | 4.60% | -9.42% | |
39 Underperform | HK$181.64M | -0.57 | 32.54% | ― | -45.11% | 16.34% | |
39 Underperform | HK$259.86M | -0.21 | -40.16% | ― | -27.42% | -80.52% |